Delin Wang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Delin Wang has a total of 155 co-authors. Here are the top co-authors by number of shared publications:
Shuai Su
Department of Urology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China
8 shared publicationsYu Luo
Department of Urology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China
8 shared publicationsJindong Zhang
Department of Urology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China
7 shared publicationsKun Han
Department of Urology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China
6 shared publicationsJiang He
Gastroenterology and Neurology Center, University‑Town Hospital of Chongqing Medical University, Chongqing 400016, P.R. China
5 shared publicationsLiangdong Song
Department of Urology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China
5 shared publications
Latest Publications
- Open Access
- 28 February 2026
- Published by Springer Nature in BMC Biotechnology
- Vol. 26 (1)
Nanoparticles co-loaded with bacillus Calmette-Guérin pure protein derivative and doxorubicin for bladder tumor therapy
Bladder perfusion chemotherapy remains the standard treatment for bladder cancer, yet its effectiveness is frequently limited by rapid drug clearance throu
- 28 February 2026
- Published by Springer Nature in BMC Biotechnology
- Vol. 26 (1)
Open AccessNanoparticles co-loaded with bacillus Calmette-Guérin pure protein derivative and doxorubicin for bladder tumor therapy
Bladder perfusion chemotherapy remains the standard treatment for bladder cancer, yet its effectiveness is frequently limited by rapid drug clearance throu
- 2 November 2025
- Published by Wiley in Molecular Carcinogenesis
- Vol. 65 (1) , 138-145
NSUN2 Promotes Prostate Cancer Cell Proliferation and Migration Through m5C Modifications of YES1
Prostate cancer (PCa) is one of the most common genitourinary malignancies in men worldwide. As a 5‐methylcytosine (m5C) methyltransferase, NSUN2 has been implicated in regulating PCa progression. This study aimed to investigate the role of NSUN2 in PCa and elucidate its underlying mechanisms. The biological behaviors of PCa cells were assessed using Cell Counting Kit‐8, EdU incorporation, and Transwell assays. The expression levels of relevant RNAs were determined via quantitative real‐time PCR. The interaction between NSUN2 and YES proto‐oncogene 1 (YES1) was examined through methylated RNA immunoprecipitation (MeRIP), RNA immunoprecipitation (RIP), and dual‐luciferase reporter assays. Results showed that NSUN2 was elevated in PCa, and its downregulation suppressed cell viability, proliferation, migration, and invasion. Mechanistically, NSUN2 interacted with YES1 and stabilized its mRNA by promoting m5C modification on YES1. The oncogenic role of NSUN2 was further confirmed in xenograft models in vivo. In conclusion, our study demonstrated that NSUN2 facilitated malignant proliferation and migration of PCa cells by enhancing YES1 mRNA stability via m5C modification. These findings suggested that both NSUN2 and YES1 may serve as potential therapeutic targets for PCa, offering new strategies for treatment.
- 2 November 2025
- Published by Wiley in Molecular Carcinogenesis
- Vol. 65 (1) , 138-145
NSUN2 Promotes Prostate Cancer Cell Proliferation and Migration Through m5C Modifications of YES1
Prostate cancer (PCa) is one of the most common genitourinary malignancies in men worldwide. As a 5‐methylcytosine (m5C) methyltransferase, NSUN2 has been implicated in regulating PCa progression. This study aimed to investigate the role of NSUN2 in PCa and elucidate its underlying mechanisms. The biological behaviors of PCa cells were assessed using Cell Counting Kit‐8, EdU incorporation, and Transwell assays. The expression levels of relevant RNAs were determined via quantitative real‐time PCR. The interaction between NSUN2 and YES proto‐oncogene 1 (YES1) was examined through methylated RNA immunoprecipitation (MeRIP), RNA immunoprecipitation (RIP), and dual‐luciferase reporter assays. Results showed that NSUN2 was elevated in PCa, and its downregulation suppressed cell viability, proliferation, migration, and invasion. Mechanistically, NSUN2 interacted with YES1 and stabilized its mRNA by promoting m5C modification on YES1. The oncogenic role of NSUN2 was further confirmed in xenograft models in vivo. In conclusion, our study demonstrated that NSUN2 facilitated malignant proliferation and migration of PCa cells by enhancing YES1 mRNA stability via m5C modification. These findings suggested that both NSUN2 and YES1 may serve as potential therapeutic targets for PCa, offering new strategies for treatment.
- Open Access
- 1 October 2025
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 15, 1523794
Comparing the risk of cardiovascular disease between degarelix and gonadotropin-releasing hormone agonists:a systematic review and meta-analysis
Background: Regarding the comparison of cardiovascular disease risk between gonadotropin-releasing hormone (GnRH) antagonists and GnRH agonists, there are discrepancies in results from different studies. Therefore, this meta-analysis was conducted to investigate whether degarelix could reduce cardiovascular disease risk.Methods: We systematically searched the PubMed, Embase, Web of Science, and Cochrane Library databases with a search time limit of up to December 2023 for articles focusing on the use of degarelix, a GnRH antagonist, in prostate cancer, with an emphasis on articles comparing degarelix to GnRH agonists. Study endpoints included major adverse cardiovascular events, stroke, all-cause mortality, myocardial infarction, heart failure, and arrhythmia.Results: A total of 1320 articles were retrieved, of which eight met our inclusion criteria and involved 138–065 patients. The pooled results showed no difference in the risk of major adverse cardiovascular events (hazard ratio [HR]=0.94, 95% confidence interval [CI]: 0.65–1.35; P=0.73), stroke (HR=0.89, 95% CI: 0.62–1.27; P=0.52), myocardial infarction (HR=0.98, 95% CI: 0.70–1.37; P=0.91), all-cause mortality (HR=1.09, 95% CI: 0.73–1.65; P=0.67), and arrhythmia (risk ratio=0.64, 95% CI: 0.15–2.76; P=0.55) between degarelix and GnRH agonists. However, degarelix reduced the risk of heart failure (HR=0.56, 95% CI: 0.36–0.88; P=0.01).Conclusion: Further clarification on the effects of different androgen deprivation therapy modalities on cardiovascular disease is needed from future and larger prospective randomized controlled trials.
- 1 October 2025
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 15, 1523794
Open AccessComparing the risk of cardiovascular disease between degarelix and gonadotropin-releasing hormone agonists:a systematic review and meta-analysis
Background: Regarding the comparison of cardiovascular disease risk between gonadotropin-releasing hormone (GnRH) antagonists and GnRH agonists, there are discrepancies in results from different studies. Therefore, this meta-analysis was conducted to investigate whether degarelix could reduce cardiovascular disease risk.Methods: We systematically searched the PubMed, Embase, Web of Science, and Cochrane Library databases with a search time limit of up to December 2023 for articles focusing on the use of degarelix, a GnRH antagonist, in prostate cancer, with an emphasis on articles comparing degarelix to GnRH agonists. Study endpoints included major adverse cardiovascular events, stroke, all-cause mortality, myocardial infarction, heart failure, and arrhythmia.Results: A total of 1320 articles were retrieved, of which eight met our inclusion criteria and involved 138–065 patients. The pooled results showed no difference in the risk of major adverse cardiovascular events (hazard ratio [HR]=0.94, 95% confidence interval [CI]: 0.65–1.35; P=0.73), stroke (HR=0.89, 95% CI: 0.62–1.27; P=0.52), myocardial infarction (HR=0.98, 95% CI: 0.70–1.37; P=0.91), all-cause mortality (HR=1.09, 95% CI: 0.73–1.65; P=0.67), and arrhythmia (risk ratio=0.64, 95% CI: 0.15–2.76; P=0.55) between degarelix and GnRH agonists. However, degarelix reduced the risk of heart failure (HR=0.56, 95% CI: 0.36–0.88; P=0.01).Conclusion: Further clarification on the effects of different androgen deprivation therapy modalities on cardiovascular disease is needed from future and larger prospective randomized controlled trials.
- Open Access
- 1 August 2025
- Published by AME Publishing Company in Translational Andrology and Urology
- Vol. 14 (8) , 2289-2301
A bibliometric study of the top 100 most-cited papers in ureteral stricture reconstruction
Background: Ureteral stricture is caused by iatrogenic and non-iatrogenic factors. The treatment of ureteral stricture usually involves ureteral reconstruction. This study aimed to identify and analyze the top 100 most cited (T100) papers in ureteral stricture reconstruction, a field lacking prior bibliometric analysis. Methods: Using the Web of Science Core Collection, we retrieved the T100 articles and review articles on ureteral stricture reconstruction and applied bibliometric tools (CiteSpace, VOSviewer, Bibliometrix) to examine citation patterns, authorship, geographic distribution, journal distribution, co-citation networks, and keyword trends. Results: The T100 articles received 4 to 130 citations each, with an average of 25.13. Publications originated from 23 countries, with the USA leading (56 papers, 1,635 total citations) followed by China (17 papers). Temple University (USA, 12 papers) and Peking University (China, 9 papers) were among the most productive institutions. Daniel D. Eun was the top contributing author (12 papers). Urology, Journal of Endourology, and Journal of Urology were the most productive journals. Topic and keywords analysis shows the hot spots of mucosa grafts and robot-assisted surgery. Conclusions: Our study provides a comprehensive overview of influential literature in ureteral stricture reconstruction. Ureteral stricture reconstruction is an emerging research field. Mucosa grafts and robot-assisted surgery are likely to be hot topics in the future.
- 1 August 2025
- Published by AME Publishing Company in Translational Andrology and Urology
- Vol. 14 (8) , 2289-2301
Open AccessA bibliometric study of the top 100 most-cited papers in ureteral stricture reconstruction
Background: Ureteral stricture is caused by iatrogenic and non-iatrogenic factors. The treatment of ureteral stricture usually involves ureteral reconstruction. This study aimed to identify and analyze the top 100 most cited (T100) papers in ureteral stricture reconstruction, a field lacking prior bibliometric analysis. Methods: Using the Web of Science Core Collection, we retrieved the T100 articles and review articles on ureteral stricture reconstruction and applied bibliometric tools (CiteSpace, VOSviewer, Bibliometrix) to examine citation patterns, authorship, geographic distribution, journal distribution, co-citation networks, and keyword trends. Results: The T100 articles received 4 to 130 citations each, with an average of 25.13. Publications originated from 23 countries, with the USA leading (56 papers, 1,635 total citations) followed by China (17 papers). Temple University (USA, 12 papers) and Peking University (China, 9 papers) were among the most productive institutions. Daniel D. Eun was the top contributing author (12 papers). Urology, Journal of Endourology, and Journal of Urology were the most productive journals. Topic and keywords analysis shows the hot spots of mucosa grafts and robot-assisted surgery. Conclusions: Our study provides a comprehensive overview of influential literature in ureteral stricture reconstruction. Ureteral stricture reconstruction is an emerging research field. Mucosa grafts and robot-assisted surgery are likely to be hot topics in the future.
- Open Access
- 4 July 2025
- Published by Spandidos Publications in Oncology Reports
- Vol. 54 (3) , 1-17
Widespread activation and critical role of EMT and stemness in the neuroendocrine differentiation of prostate cancer (Review)
Neuroendocrine (NE) prostate cancer (NEPC) is an aggressive and lethal subtype of prostate cancer. It is typically characterized by the expression of NE markers and the loss of androgen receptor expression. De novo NEPC is rare, accounting for <2% of all prostate cancer cases at diagnosis. More commonly, NEPC arises from prostate adenocarcinoma following androgen deprivation therapy, with 20‑25% of metastatic castration‑resistant prostate cancers undergoing NE differentiation due to lineage plasticity. During this transition, pathways associated with epithelial‑mesenchymal transition (EMT) and stemness are broadly activated, which is considered to be a key driver of NEPC's high metastatic potential, resistance to chemotherapy and radiotherapy and poor prognosis. EMT facilitates metastasis by enhancing cellular motility and invasiveness, while stemness properties contribute to post‑metastatic colonization, immune evasion, therapy resistance and cellular dormancy. As manifestations of cellular plasticity, these processes share overlapping molecular mechanisms. Targeting key regulators within these pathways may offer promising therapeutic strategies for NEPC.
- 4 July 2025
- Published by Spandidos Publications in Oncology Reports
- Vol. 54 (3) , 1-17
Open AccessWidespread activation and critical role of EMT and stemness in the neuroendocrine differentiation of prostate cancer (Review)
Neuroendocrine (NE) prostate cancer (NEPC) is an aggressive and lethal subtype of prostate cancer. It is typically characterized by the expression of NE markers and the loss of androgen receptor expression. De novo NEPC is rare, accounting for <2% of all prostate cancer cases at diagnosis. More commonly, NEPC arises from prostate adenocarcinoma following androgen deprivation therapy, with 20‑25% of metastatic castration‑resistant prostate cancers undergoing NE differentiation due to lineage plasticity. During this transition, pathways associated with epithelial‑mesenchymal transition (EMT) and stemness are broadly activated, which is considered to be a key driver of NEPC's high metastatic potential, resistance to chemotherapy and radiotherapy and poor prognosis. EMT facilitates metastasis by enhancing cellular motility and invasiveness, while stemness properties contribute to post‑metastatic colonization, immune evasion, therapy resistance and cellular dormancy. As manifestations of cellular plasticity, these processes share overlapping molecular mechanisms. Targeting key regulators within these pathways may offer promising therapeutic strategies for NEPC.
- 7 May 2025
- Published by Springer Nature in Journal of Robotic Surgery
- Vol. 19 (1) , 1-9
Retrospective analysis of robotic versus laparoscopic surgery in the treatment of giant pheochromocytoma and paraganglioma
To compare the safety and effectiveness of robot-assisted laparoscopic surgery and traditional laparoscopic surgery in the treatment of giant pheochromocytomas and paragangliomas (PPGL). A retrospective analysis was conducted using the data of patients who underwent surgery at our institution between January 2013 and November 2023 and whose postoperative pathological examination confirmed PPGL (n = 84). Patients were divided into the robot-assisted (n = 33) and laparoscopic (n = 51) groups. Baseline data and intraoperative and postoperative recovery conditions of the two groups were compared. There was no significant difference in the baseline data between the two groups. The time to resume food intake in the robot-assisted group was shorter than that in the laparoscopic group [2 (1–2) vs. 3 (2–3) days, p < 0.001], and the incidence of postoperative morbidity was also lower (15.2% vs. 43.1%, p = 0.009); however, operating room time was longer [265 (240–370) vs. 245 (205–297.5) min, p = 0.039], and overall hospitalization costs were higher [80336.38 (72,014.3–101,555.39) vs. 60,102.13 (43,059.205–88085.35) CNY, p = 0.003]. This study results indicate that robot-assisted laparoscopic surgery has a lower postoperative complication rate and faster postoperative gastrointestinal function recovery. However, the surgery is costlier and operating room time is longer than with traditional laparoscopic surgery. Robotic surgery can be considered for giant PPGL if the patient’s financial condition permits.
- 7 May 2025
- Published by Springer Nature in Journal of Robotic Surgery
- Vol. 19 (1) , 1-9
Retrospective analysis of robotic versus laparoscopic surgery in the treatment of giant pheochromocytoma and paraganglioma
To compare the safety and effectiveness of robot-assisted laparoscopic surgery and traditional laparoscopic surgery in the treatment of giant pheochromocytomas and paragangliomas (PPGL). A retrospective analysis was conducted using the data of patients who underwent surgery at our institution between January 2013 and November 2023 and whose postoperative pathological examination confirmed PPGL (n = 84). Patients were divided into the robot-assisted (n = 33) and laparoscopic (n = 51) groups. Baseline data and intraoperative and postoperative recovery conditions of the two groups were compared. There was no significant difference in the baseline data between the two groups. The time to resume food intake in the robot-assisted group was shorter than that in the laparoscopic group [2 (1–2) vs. 3 (2–3) days, p < 0.001], and the incidence of postoperative morbidity was also lower (15.2% vs. 43.1%, p = 0.009); however, operating room time was longer [265 (240–370) vs. 245 (205–297.5) min, p = 0.039], and overall hospitalization costs were higher [80336.38 (72,014.3–101,555.39) vs. 60,102.13 (43,059.205–88085.35) CNY, p = 0.003]. This study results indicate that robot-assisted laparoscopic surgery has a lower postoperative complication rate and faster postoperative gastrointestinal function recovery. However, the surgery is costlier and operating room time is longer than with traditional laparoscopic surgery. Robotic surgery can be considered for giant PPGL if the patient’s financial condition permits.
- Open Access
- 5 May 2025
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 15, 1541618
Interpretable multiparametric MRI radiomics-based machine learning model for preoperative differentiation between benign and malignant prostate masses: a diagnostic, multicenter study
Objective: The study aimed to develop and externally validate multiparametric MRI (mpMRI) radiomics-based interpretable machine learning (ML) model for preoperative differentiating between benign and malignant prostate masses.Methods: Patients who underwent mpMRI with suspected malignant prostate masses were retrospectively recruited from two independent hospitals between May 2016 and May 2023. The prostate mass regions in T2-weighted imaging (T2WI) and diffusion-weighted imaging (DWI) MRI images were segmented by ITK-SNAP. PyRadiomics was utilized to extract radiomic features. Inter- and intraobserver correlation analysis, t-test, Spearman correlation analysis, and the least absolute shrinkage and selection operator (LASSO) algorithm with a five-fold cross-validation were applied for feature selection. Five ML learning models were built using the chosen features. Model performance was evaluated with internal and external validation, using area under the curve (AUC), calibration curves, and decision curve analysis to select the optimal model. The interpretability of the most robust model was conducted via SHapley Additive exPlanation (SHAP).Results: A total of 567 patients were enrolled, consisting of the training (n = 352), internal test (n = 152), and external test (n = 63) sets. In total, 2,632 radiomic features were extracted from regions of interest (ROIs) of T2WI and DWI images, which were reduced to 18 via LASSO. Five ML models were established, among which the random forest (RF) model presented the best predictive ability, with AUCs of 0.929 (95% confidential interval [CI]: 0.885–0.963) and 0.852 (95% CI: 0.758–0.934) in the internal and external test sets, respectively. The calibration and decision curve analyses confirmed the excellent clinical usefulness of the RF model. Besides, the contributing relations of the radiomic features were uncovered using SHAP.Conclusions: Radiomic features from mpMRI combined with machine learning facilitate accurate preoperative evaluation of the malignancy in prostate masses. SHAP can disclose the underlying prediction process of the ML model, which may promote its clinical applications.
- 5 May 2025
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 15, 1541618
Open AccessInterpretable multiparametric MRI radiomics-based machine learning model for preoperative differentiation between benign and malignant prostate masses: a diagnostic, multicenter study
Objective: The study aimed to develop and externally validate multiparametric MRI (mpMRI) radiomics-based interpretable machine learning (ML) model for preoperative differentiating between benign and malignant prostate masses.Methods: Patients who underwent mpMRI with suspected malignant prostate masses were retrospectively recruited from two independent hospitals between May 2016 and May 2023. The prostate mass regions in T2-weighted imaging (T2WI) and diffusion-weighted imaging (DWI) MRI images were segmented by ITK-SNAP. PyRadiomics was utilized to extract radiomic features. Inter- and intraobserver correlation analysis, t-test, Spearman correlation analysis, and the least absolute shrinkage and selection operator (LASSO) algorithm with a five-fold cross-validation were applied for feature selection. Five ML learning models were built using the chosen features. Model performance was evaluated with internal and external validation, using area under the curve (AUC), calibration curves, and decision curve analysis to select the optimal model. The interpretability of the most robust model was conducted via SHapley Additive exPlanation (SHAP).Results: A total of 567 patients were enrolled, consisting of the training (n = 352), internal test (n = 152), and external test (n = 63) sets. In total, 2,632 radiomic features were extracted from regions of interest (ROIs) of T2WI and DWI images, which were reduced to 18 via LASSO. Five ML models were established, among which the random forest (RF) model presented the best predictive ability, with AUCs of 0.929 (95% confidential interval [CI]: 0.885–0.963) and 0.852 (95% CI: 0.758–0.934) in the internal and external test sets, respectively. The calibration and decision curve analyses confirmed the excellent clinical usefulness of the RF model. Besides, the contributing relations of the radiomic features were uncovered using SHAP.Conclusions: Radiomic features from mpMRI combined with machine learning facilitate accurate preoperative evaluation of the malignancy in prostate masses. SHAP can disclose the underlying prediction process of the ML model, which may promote its clinical applications.
- Open Access
- 20 March 2025
- Published by Elsevier in Journal of Bone Oncology
- Vol. 52, 100673
A novel bone metastasis-related gene signature for predicting prognosis, anti-androgen resistance, and drug choice in prostate cancer
- 20 March 2025
- Published by Elsevier in Journal of Bone Oncology
- Vol. 52, 100673
Open AccessA novel bone metastasis-related gene signature for predicting prognosis, anti-androgen resistance, and drug choice in prostate cancer
- Open Access
- 11 March 2025
- Published by Elsevier in Asian Journal of Surgery
- Vol. 48 (8) , 5078-5079
Robot-assisted laparoscopic surgical intervention of a large pheochromocytoma with catecholamine crisis: A case report
- 11 March 2025
- Published by Elsevier in Asian Journal of Surgery
- Vol. 48 (8) , 5078-5079
Open AccessRobot-assisted laparoscopic surgical intervention of a large pheochromocytoma with catecholamine crisis: A case report
- Open Access
- 1 March 2025
- Published by AME Publishing Company in Gland Surgery
- Vol. 14 (3) , 436-450
Frontiers and hotspots of 3D technology in prostatectomy from 1999 to 2024: a bibliometric analysis and visualization
Background: Prostate cancer is a major global health issue. Radical prostatectomy is an effective treatment for prostate cancer. The integration of three-dimensional (3D) technology in prostatectomy offers numerous benefits. We intended to perform a bibliometric analysis of the role of 3D technology in prostatectomy. Methods: Articles and review articles related to “3D” and “prostatectomy” were retrieved from Web of Science Core Collection. Microsoft Office Excel, CiteSpace, and VOSviewer were utilized for analysis and visualization. Results: A total of 441 articles were collected. The annual publication volume and journal distribution were illustrated. Visualizations of collaborations among countries/regions, institutions, and authors were provided. Networks of reference co-citations and keyword co-occurrences, along with their respective clusters were plotted. Conclusions: The number of published papers significantly increased over the last 25 years. The most productive and influential country was the USA, and The University of California System was the most influential institution. The journal with the highest number of publications was BJU International. Among all authors in this field, Wijkstra H has published the most papers. Porpiglia F was the most cited author. Previous hot topics included advanced imaging and clinical trials, whereas augmented reality (AR) and robotics are likely to be hot topics in the future.
- 1 March 2025
- Published by AME Publishing Company in Gland Surgery
- Vol. 14 (3) , 436-450
Open AccessFrontiers and hotspots of 3D technology in prostatectomy from 1999 to 2024: a bibliometric analysis and visualization
Background: Prostate cancer is a major global health issue. Radical prostatectomy is an effective treatment for prostate cancer. The integration of three-dimensional (3D) technology in prostatectomy offers numerous benefits. We intended to perform a bibliometric analysis of the role of 3D technology in prostatectomy. Methods: Articles and review articles related to “3D” and “prostatectomy” were retrieved from Web of Science Core Collection. Microsoft Office Excel, CiteSpace, and VOSviewer were utilized for analysis and visualization. Results: A total of 441 articles were collected. The annual publication volume and journal distribution were illustrated. Visualizations of collaborations among countries/regions, institutions, and authors were provided. Networks of reference co-citations and keyword co-occurrences, along with their respective clusters were plotted. Conclusions: The number of published papers significantly increased over the last 25 years. The most productive and influential country was the USA, and The University of California System was the most influential institution. The journal with the highest number of publications was BJU International. Among all authors in this field, Wijkstra H has published the most papers. Porpiglia F was the most cited author. Previous hot topics included advanced imaging and clinical trials, whereas augmented reality (AR) and robotics are likely to be hot topics in the future.